Quantum Cyber N.V. Dividends Received Classified As Operating Activities
Quantum Cyber N.V. (QUCY) reported Dividends Received Classified As Operating Activities of $6.50 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:DividendsReceivedClassifiedAsOperatingActivities · last filed 2025-09-26
- Quantum Cyber N.V. dividends received classified as operating activities for the quarter ending 2023-12-31 was $4.66M.
- Quantum Cyber N.V. dividends received classified as operating activities for the quarter ending 2023-09-30 was $6.51M.
- Quantum Cyber N.V. dividends received classified as operating activities for the quarter ending 2023-06-30 was $5.12M.
- Quantum Cyber N.V. dividends received classified as operating activities for the quarter ending 2023-03-31 was $5.66M.
| Period end | Dividends Received Classified As Operating Activities | Dividends Received Classified As Operating Activities 3 month | Dividends Received Classified As Operating Activities 6 month | Dividends Received Classified As Operating Activities 9 month | Dividends Received Classified As Operating Activities 12 month |
|---|---|---|---|---|---|
| 2025-06-30 | $6.50M 6-K · filed 2025-09-26 | ||||
| 2024-12-31 | $17.09M 20-F · filed 2025-03-31 | ||||
| 2024-06-30 | $8.10M 6-K · filed 2024-10-18 | ||||
| 2023-12-31 | $4.66M derived: 20-F 12 month − 6-K 9 month · filed 2024-04-09 | $11.16M derived: sum of 2 quarters · filed 2024-04-09 | $16.28M derived: sum of 3 quarters · filed 2024-04-09 | $21.94M 20-F · filed 2024-04-09 | |
| 2023-09-30 | $6.51M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-16 | $11.62M derived: sum of 2 quarters · filed 2023-11-16 | $17.28M 6-K · filed 2023-11-16 | ||
| 2023-06-30 | $5.12M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | $10.78M 6-K · filed 2023-08-15 | |||
| 2023-03-31 | $5.66M 6-K · filed 2023-05-16 | ||||
| 2022-12-31 | $14.77M 20-F · filed 2023-04-07 | ||||
| 2022-06-30 | $6.46M 6-K · filed 2022-09-07 | ||||
| 2021-12-31 | $3.22M 20-F · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |